IBISWorld Platform
Answer any industry question in minutes with our entire database at your fingertips.
Arthritis New Zealand (Mateponapona Aotearoa)
Arthritis New Zealand (Mateponapona Aotearoa) is a Trust that generates the majority of its income from the Community Services industry. In 2024 the company generated total revenue of $2,944,000 including sales and other revenue. The exact number of employees for this organisation is not available. The Chief Executive of Arthritis New Zealand (Mateponapona Aotearoa) is Mr Philip Kearney whose official title is Chief Executive. The Chairman of Arthritis New Zealand (Mateponapona Aotearoa) is Ms Rebecca Roberts whose official title is Chair. Arthritis New Zealand (Mateponapona Aotearoa) advocate for people with arthritis by funding research, contributing to health policy, and collaborating with healthcare professionals. The trust offers the following support services: Advocacy Arthritis Assist Arthritis IQ Courses Children with Arthritis MyJoint Pain (Osteoarthritis) MyRA (Rheumatoid Arthritis) Peer Support Service Resources Support Groups Webinars & Videos
Access this data your way
The Arthritis New Zealand (Mateponapona Aotearoa) Industry analysis is available in multiple formats to fit seamlessly into your workflow.
API Data Delivery
Feed trusted, human-driven industry intelligence straight into your platform.
Integrations
Streamline your workflow with IBISWorld’s intelligence built into your toolkit.
What's included in this industry analysis
IBISWorld's research coverage on the Arthritis New Zealand (Mateponapona Aotearoa) includes market sizing, forecasting, data and analysis. The most recent publication will be as current as of March 2026.
Company Details
What’s this enterprise profile about?
Arthritis New Zealand (Mateponapona Aotearoa), trading as Arthritis New Zealand (Mateponapona Aotearoa), operates under the ABN and was incorporated on 01 July 2018. Arthritis New Zealand (Mateponapona Aotearoa) primarily operates in the Community Services industry in Australia.
Key Personnel
What’s included in the Key Personnel chapter?
The Key Personnel chapter outlines the principal leadership positions within Arthritis New Zealand (Mateponapona Aotearoa), including the Chairman, Board members, Chief Executive Officer, and other key management personnel. It provides an overview of the company’s governance and executive structure, along with a breakdown of gender diversity across leadership roles, offering insight into the composition of the organisation’s senior team.
Financials
What’s included in the Financials chapter?
The Financials chapter presents Arthritis New Zealand (Mateponapona Aotearoa)’s historical financial performance, including detailed profit and loss statements outlining sales revenue, cost of sales, and profitability. It also incorporates balance sheet data, providing a breakdown of assets and liabilities, as well as additional financial metrics such as the number of shares on issue. Together, these disclosures offer a comprehensive view of the company’s financial position and performance over time.
Growth & Ratios
What’s included in the Growth & Rations chapter?
The Growth & Ratios chapter provides historical data on key financial performance indicators, enabling an assessment of the company’s operational efficiency, profitability, and financial structure over time. Metrics covered include return on equity, return on assets, profit margins, revenue per employee, as well as gearing and leverage ratios, offering a comprehensive view of performance trends and capital management.
Operating Segments
What’s included in the Operating Segments chapter?
The Operating Segments chapter provides an overview of the revenue composition and asset allocation across the various industries in which Arthritis New Zealand (Mateponapona Aotearoa) operates. It offers insights into how the company’s financial performance is distributed among its core business segments, highlighting the relative contribution of each industry to total revenue.
Competitor Benchmarking
What’s included in the Competitor Benchmarking chapter?
The Competitor Benchmarking chapter includes a comparative assessment of Arthritis New Zealand (Mateponapona Aotearoa)’s key financial, growth, and valuation ratios against industry averages to evaluate its competitive position. It analyses valuation metrics such as price-to-earnings, price-to-book, enterprise value to EBITDA, and enterprise value to sales, alongside core financial indicators including liquidity ratios and profitability measures.
Industries of Operation
What’s included in the Industries of Operation chapter?
The Industries of Operation chapter outlines Arthritis New Zealand (Mateponapona Aotearoa)’s market share across the industries in which it operates. Each industry profile includes a comprehensive overview featuring data on total market size, the number of enterprises, industry concentration levels, and overall turnover. This analysis provides context for the company’s competitive position and scale within each relevant market.
Shareholders
What’s included in the Shareholders chapter?
The Shareholders chapter provides a breakdown of the ownership structure of Arthritis New Zealand (Mateponapona Aotearoa), identifying key shareholders and outlining their respective ownership interests. This section offers insight into the concentration of shareholdings, the presence of institutional or strategic investors, and the overall distribution of equity within the company.
Subsidiaries
What’s included in the Subsidiaries chapter?
The Subsidiaries chapter provides an overview of the companies and business entities that are wholly or partially owned by Arthritis New Zealand (Mateponapona Aotearoa). It outlines the ownership structure of each subsidiary, offering insight into the broader corporate group and how these entities contribute to the company’s overall activities and performance.
History
What’s included in the History chapter?
The History chapter presents a overview of Arthritis New Zealand (Mateponapona Aotearoa)’s development, highlighting key milestones and significant corporate events since its incorporation. It includes the company’s incorporation date and outlines major strategic, operational, and structural developments, providing context for its evolution and current market position.
Trusted by industry professionals
More than 6,000 businesses use IBISWorld to shape local and global economies
We were able to supplement our reports with IBISWorld’s information from both a qualitative and quantitative standpoint. All of our reporting now features some level of IBISWorld integration.
IBISWorld delivers the crisp business knowledge we need to drive our business. Whether it be serving up our major clients, winning new business or educating on industry issues, IBISWorld brings real value.
IBISWorld has revolutionised business information — which has proved commercially invaluable to exporters, investors and public policy professionals in Australia and overseas.
When you’re able to speak to clients and be knowledgeable about what they do and the state that they operate in, they’re going to trust you a lot more.
Frequently Asked Questions
What is Arthritis New Zealand (Mateponapona Aotearoa)?
Arthritis New Zealand (Mateponapona Aotearoa) advocate for people with arthritis by funding research, contributing to health policy, and collaborating with healthcare professionals. The trust offers the following support services: Advocacy Arthritis Assist Arthritis IQ Courses Children with Arthritis MyJoint Pain (Osteoarthritis) MyRA (Rheumatoid Arthritis) Peer Support Service Resources Support Groups Webinars & Videos
What industry does Arthritis New Zealand (Mateponapona Aotearoa) operate in?
Arthritis New Zealand (Mateponapona Aotearoa), trading as Arthritis New Zealand (Mateponapona Aotearoa), is a Private Company that generates the majority of its income from the Community Services industry in Australia.
Where is Arthritis New Zealand (Mateponapona Aotearoa) located?
Murray Cod Australia Limited company is based at 120 Featherston Street, Wellington, New Zealand, New Zealand.
Who is the CEO of Arthritis New Zealand (Mateponapona Aotearoa)?
The Chief Executive of Arthritis New Zealand (Mateponapona Aotearoa) is Rebecca Roberts and the Chief Executive is Philip Kearney.
What was Arthritis New Zealand (Mateponapona Aotearoa)’s revenue in 2025?
In 2025, Arthritis New Zealand (Mateponapona Aotearoa) generated total revenue of approximately $2.9 million.
Cut through the noise with intelligence you can trust
